Description     Claims     Drawing  

WO2008005457A   [0007]  [0007] 

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo   [0006]  [0125] 
Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells CHARACTERIZATION OF A SELECTIVE ALLOSTERIC KINASE INHIBITOR   [0007] 
Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy   [0113]  [0125] 
Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells   [0114]  [0130] 
Somatic mutations of PTEN in glioblastoma multiforme   [0118] 
SU2C Phase Ib Study of Paclitaxel and MK-2206 in Advanced Solid Tumors and Metastatic Breast Cancer   [0122] 
Ceramide induces the dephosphorylation and inhibition of constitutively activated Akt in PTEN negative U87mg cells   [0122]